Skip to content

Not applicable

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518150-17-00
Acronym
CLI-10196AA1-01
Enrollment
40
Registered
2025-01-15
Start date
2025-03-10
Completion date
2025-08-13
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-cystic fibrosis bronchiectasis

Interventions

None listed

Sponsors

Chiesi Farmaceutici S.p.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026